Skip to content
Search

Latest Stories

DHSC grants final November price concessions

The Pharmaceutical Services Negotiating Committee has announced that the Department of Health and Social Care (DHSC) has granted final price concessions to further items for the month of November 2021.

DrugPack sizePrice Concession
Co-amilozide 5mg/50mg tablets28£8.98
Co-dydramol 10mg/500mg tablets100£6.19
Co-dydramol 10mg/500mg tablets30£1.86
Omeprazole 10mg/5ml oral suspension sugar free75£106.46
Omeprazole 20mg/5ml oral suspension sugar free75£206.00
Prednisolone 5mg soluble tablets30£10.35
Simvastatin 20mg/5ml oral suspension sugar free150£173.89
Simvastatin 40mg/5ml oral suspension sugar free150£250.63
Sulfasalazine 500mg gastro-resistant tablets112£23.12
Sulfasalazine 500mg tablets112£21.35
Topiramate 100mg tablets60£8.09
Topiramate 25mg tablets60£2.89
Topiramate 50mg tablets60£3.52
Trazodone 100mg capsules56£3.50
Trazodone 150mg tablets28£3.31

The DHSC previously announced (26.11.2021) the following list of price concessions:


DrugPack sizePrice Concession
Amisulpride 50mg tablets60£2.99
Donepezil 1mg/ml oral solution sugar free150£81.23
Ivabradine 5mg tablets56£7.87
Lercanidipine 20mg tablets28£3.04
Metformin 500mg/5ml oral solution sugar free150£36.15
Mirtazapine 15mg/ml oral solution sugar free66£97.89
Orphenadrine 50mg/5ml oral solution sugar free150£87.09
Procyclidine 2.5mg/5ml oral solution sugar free150£37.39
Procyclidine 5mg/5ml oral solution sugar free150£55.61
Promazine 25mg/5ml oral solution150£60.19
Promazine 50mg/5ml oral solution150£75.36
Quetiapine 20mg/ml oral suspension sugar free150£166.31
Ramipril 2.5mg/5ml oral solution sugar free150£164.12
Ropinirole 1mg tablets84£56.71
Sodium fluoride 0.05% mouthwash sugar free250£1.57
Sulfasalazine 250mg/5ml oral suspension sugar free500£94.22
Tamoxifen 10mg/5ml oral solution sugar free150£74.52
Timolol 0.25% eye drops5£3.73
Trihexyphenidyl 5mg/5ml oral solution200£82.54
Trimethoprim 100mg tablets28£2.10
Warfarin 1mg/ml oral suspension sugar free150£156.07

The DHSC previously announced (19.11.2021) the following list of price concessions:

DrugPack sizePrice Concession
Celecoxib 100mg capsules60£1.80
Celecoxib 200mg capsules30£1.75
Cinnarizine 15mg tablets84£3.97
Clomipramine 10mg capsules28£2.76
Clomipramine 25mg capsules28£4.85
Clomipramine 50mg capsules28£8.25
Enalapril 10mg tablets28£5.29
Enalapril 5mg tablets28£7.15
Fludrocortisone 100microgram tablets30£11.20
Lamotrigine 5mg dispersible tablets sugar free28£8.35
Lansoprazole 30mg orodispersible tablets28£5.18
Lercanidipine 10mg tablets28£2.99
Loratadine 5mg/5ml oral solution100£6.46
Methocarbamol 750mg tablets100£12.95
Naftidrofuryl 100mg capsules84£7.79
Nitrofurantoin 50mg capsules30£10.49
Orlistat 120mg capsules84£24.22
Pioglitazone 30mg tablets28£2.70
Pioglitazone 45mg tablets28£2.70
Timolol 0.5% eye drops5£3.77
Tolbutamide 500mg tablets28£25.75
Tolterodine 1mg tablets56£3.46
Tolterodine 2mg tablets56£4.82
Trazodone 50mg capsules84£3.45
Trimethoprim 50mg/5ml oral suspension sugar free100£10.75
Ursodeoxycholic acid 250mg capsules60£10.27

A price concession only applies for the month in which it is granted. No additional prescription endorsement are required as the new price is automatically applied by the NHS BSA to all items submitted for payment in the same month for which a price concession is granted.

Contractors can find information and learn about the process involved on PSNC’s website.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less